Vicarious Surgical (NYSE:RBOT) Receives Neutral Rating from BTIG Research

Vicarious Surgical (NYSE:RBOT)‘s stock had its “neutral” rating reaffirmed by equities research analysts at BTIG Research in a research report issued on Friday,Benzinga reports.

A number of other research firms have also weighed in on RBOT. Wall Street Zen raised Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, October 8th. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Trading Down 4.4%

NYSE RBOT opened at $2.59 on Friday. Vicarious Surgical has a 1-year low of $2.44 and a 1-year high of $18.97. The stock has a 50-day moving average of $4.39 and a 200-day moving average of $6.49. The firm has a market cap of $16.96 million, a PE ratio of -0.29 and a beta of 1.51.

Vicarious Surgical (NYSE:RBOT) last issued its earnings results on Wednesday, November 12th. The company reported ($1.91) earnings per share for the quarter, beating the consensus estimate of ($2.37) by $0.46. As a group, equities research analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Vicarious Surgical

Several hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP lifted its stake in Vicarious Surgical by 22.1% in the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after acquiring an additional 3,615 shares during the period. Connective Capital Management LLC purchased a new position in Vicarious Surgical during the 3rd quarter valued at $169,000. Finally, DNB Asset Management AS raised its holdings in Vicarious Surgical by 12.1% in the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after purchasing an additional 3,154 shares in the last quarter. 47.27% of the stock is owned by hedge funds and other institutional investors.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.